Synedica Retatrutide and the Future of Metabolic Health
What Is Synedica Retatrutide Synedica retatrutide refers to retatrutide being discussed in connection with Synedica and the growing interest in next-generation metabolic treatments. Retatrutide is an investigational medicine designed to act on three hormone pathways: GLP-1, GIP, and glucagon. This multi-pathway approach has attracted considerable attention because these hormones influence appetite, blood sugar regulation, and